Pliant Therapeutics Inc Share Price Today: Live Updates & Key Insights

Pliant Therapeutics Inc share price today is $1.29, up -3.01%. The stock opened at $1.32 against the previous close of $1.33, with an intraday high of $1.325 and low of $1.27.

Pliant Therapeutics Inc Share Price Chart

Pliant Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Pliant Therapeutics Inc Share Price Performance

$1.29 -0.0301(-3.01%) PLRX at 23 Mar 2026 02:46 PM Biotechnology
Lowest Today 1.27
Highest Today 1.325
Today’s Open 1.32
Prev. Close 1.33
52 Week High 1.95
52 Week Low 1.09
Day’s Range: Low 1.27 High 1.325
52-Week Range: Low 1.09 High 1.95
1 day return -
1 Week return -2.28
1 month return +3.62
3 month return +3.21
6 month return -14.33
1 year return -19.68
3 year return -95.1
5 year return -96.63
10 year return -

Pliant Therapeutics Inc Institutional Holdings

TANG CAPITAL MANAGEMENT LLC 9.77

Point72 Asset Management, L.P. 7.06

JPMorgan Chase & Co 6.93

Morgan Stanley - Brokerage Accounts 5.71

Blue Owl Capital Holdings LP 4.83

Vanguard Group Inc 4.59

Citadel Advisors Llc 4.20

Acadian Asset Management LLC 3.86

Woodline Partners LP 3.30

Vanguard Total Stock Mkt Idx Inv 2.84

Redmile Group, LLC 2.59

Prosight Management, LP 2.53

BML Capital Management LLC 2.52

BlackRock Inc 2.31

UBS Group AG 2.15

Two Sigma Advisers, LLC 2.03

Marshall Wace Asset Management Ltd 1.76

Renaissance Technologies Corp 1.70

Centiva Capital LP 1.63

Two Sigma Investments LLC 1.55

Peapod Lane Capital LLC 1.44

Vanguard Institutional Extnd Mkt Idx Tr 0.91

Sun Life Global Mid Cap Fund I 0.61

Bridgeway Ultra-Small Company 0.39

Fidelity Extended Market Index 0.32

iShares Micro-Cap ETF 0.24

Blackrock Extended Mkt Fund CF 0.20

Vanguard Health Care ETF 0.19

Invesco RAFI US 1500 Small-Mid ETF 0.19

Extended Equity Market Fund K 0.17

Fidelity Total Market Index 0.15

Bridgeway Ultra-Small Company Market 0.13

Fidelity Series Total Market Index 0.12

Spartan Extended Market Index Pool F 0.12

Northern Trust Extended Eq Market Idx 0.10

NT Ext Equity Mkt Idx Fd - L 0.08

Vanguard Instl Ttl Stck Mkt Idx Tr 0.07

Spartan Total Market Index Pool G 0.07

NT Ext Equity Mkt Idx Fd - NL 0.07

GuideStone Funds Small Cap Equity Instl 0.06

Pliant Therapeutics Inc Market Status

Strong Buy: 1

Buy: 1

Hold: 11

Sell: 0

Strong Sell: 0

Pliant Therapeutics Inc Fundamentals

Market Cap 79.87 M

PB Ratio 0.451

PE Ratio 0.0

Enterprise Value -79.49 M

Total Assets 225.23 M

Volume 443373

Pliant Therapeutics Inc Company Financials

Annual Revenue FY23:3545000 3.5M, FY22:9685000 9.7M, FY21:7572000 7.6M, FY20:41817000 41.8M, FY19:57052000 57.1M

Annual Profit FY23:null 0.0M, FY22:9685000 9.7M, FY21:7572000 7.6M, FY20:41817000 41.8M, FY19:57052000 57.1M

Annual Net worth FY23:-155287000 -155.3M, FY22:-121498000 -121.5M, FY21:-17907000 -17.9M, FY20:-39745000 -39.7M, FY19:185000 0.2M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:-447000 -0.4M, Q1/2025:-448000 -0.4M, Q3/2024:null 0.0M, Q2/2024:-622000 -0.6M

Quarterly Net worth Q3/2025:-26301000 -26.3M, Q2/2025:-43300000 -43.3M, Q1/2025:-56166000 -56.2M, Q3/2024:-57763000 -57.8M, Q2/2024:-55854000 -55.9M

About Pliant Therapeutics Inc & investment objective

Company Information Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Organisation Biotechnology

Employees 49

Industry Biotechnology

CEO Dr. Bernard Coulie M.B.A., M.D., Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Pliant Therapeutics Inc FAQs

What is the share price of Pliant Therapeutics Inc today?

The current share price of Pliant Therapeutics Inc is $1.29.

Can I buy Pliant Therapeutics Inc shares in India?

Yes, Indian investors can buy Pliant Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Pliant Therapeutics Inc shares in India?

You can easily invest in Pliant Therapeutics Inc shares from India by:

Can I buy fractional shares of Pliant Therapeutics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Pliant Therapeutics Inc?

Pliant Therapeutics Inc has a market cap of $79.87 M.

In which sector does Pliant Therapeutics Inc belong?

Pliant Therapeutics Inc operates in the Biotechnology sector.

What documents are required to invest in Pliant Therapeutics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Pliant Therapeutics Inc?

The PE ratio of Pliant Therapeutics Inc is N/A and the PB ratio is 0.45.